{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-045232","form_type":"8-K","ticker":"CRSP","cik":"0001674416","company_name":"CRISPR Therapeutics AG","filed_at":"2025-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.399309+00:00","generated_at":"2026-05-24T05:00:19.984856+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CRSP COO Julianne Bruno steps down effective April 11, 2025","bullets":["Julianne Bruno resigns as COO of CRISPR Therapeutics to pursue external opportunities.","Departure effective April 11, 2025; she remains an employee until that date.","Resignation not the result of any disagreement with the company.","CEO Samarth Kulkarni thanked Bruno for six years of leadership in hematology and oncology."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-045232","json":"https://secwatch.observer/filing/0000950170-25-045232.json","markdown":"https://secwatch.observer/filing/0000950170-25-045232.md","text":"https://secwatch.observer/filing/0000950170-25-045232.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025045232/0000950170-25-045232-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025045232/crsp-20250324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:00:19.984856+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"86b1cae363","claim":"Julianne Bruno resigned as Chief Operating Officer at CRISPR Therapeutics AG.","evidence_excerpt":"On March 24, 2025, Julianne Bruno informed CRISPR Therapeutics AG (the “Company”) that she would be stepping down from the Company to pursue external opportunities, effective as of April 11, 2025, and she resigned from her position as Chief Operating Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025045232/0000950170-25-045232-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Operating Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}